The information provided on EL7.AI is for educational and informational purposes only and does not constitute financial advice.

We use cookies to improve your experience and serve personalized ads.

By clicking Accept, you consent to our use of advertising cookies. See our Privacy Policy for details.

Stocks•13 February 2026•

1 min read

Drake & Associates LLC Reduces Stake in Johnson & Johnson by 32.7%

3D metallic 'PVH' text with 'CALVIN KLEIN' and 'TOMMY HILFIGER' names. Upward trend line, 'EARNINGS BEAT', 'REVENUE: +14%', and '2026 GUIDANCE' on an orange background.

Drake & Associates LLC has significantly reduced its position in Johnson & Johnson (JNJ) during the third quarter, according to recent regulatory filings. The investment firm sold 7,105 shares, representing a 32.7% decrease in its total holdings of the healthcare giant. Following this transaction, Drake & Associates now maintains 14,653 shares in the company, valued at approximately $2.725 million. Despite this institutional sell-off, Johnson & Johnson continues to demonstrate robust financial health, recently reporting earnings per share of $2.46. The company's quarterly revenue reached $24.28 billion, supporting its current "moderate buy" analyst rating. Market experts view this move as a standard portfolio rebalancing rather than a reflection of the company's underlying fundamentals.

Sources: